Related Experiment Video
Updated: Jun 6, 2026

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
Published on: October 11, 2019
Quinine for muscle cramps.
Sherif El-Tawil1, Tarique Al Musa, Haseeb Valli
1Cochrane Neuromuscular Disease Group, MRC Centre for Neuromuscular Disease, PO Box 114, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK, WC1N 3BG.
Quinine effectively reduces muscle cramp frequency, intensity, and days experienced. While minor side effects like gastrointestinal issues can occur, serious adverse events are not significantly increased compared to placebo.
Area of Science:
- Neurology
- Pharmacology
Background:
- Muscle cramps are common and can have various causes.
- Quinine is a frequently used treatment for muscle cramps, but its effectiveness and safety are debated.
Purpose of the Study:
- To evaluate the efficacy and safety of quinine for treating muscle cramps.
Main Methods:
- Conducted a systematic review of randomized controlled trials (RCTs) up to July 2010.
- Included RCTs involving individuals of all ages experiencing muscle cramps treated with quinine or its derivatives.
- Analyzed data from 23 trials involving 1586 participants.
Main Results:
- Quinine (200-500 mg/day) significantly reduced cramp number (28%), intensity (10%), and cramp days (20%) compared to placebo over two weeks.
- Minor adverse events, primarily gastrointestinal, were slightly more common with quinine (3% difference).
- No significant difference in major adverse events was observed between quinine and placebo, though one case of thrombocytopenia occurred.
Conclusions:
- Moderate-quality evidence supports quinine's efficacy in reducing cramp frequency, intensity, and days at dosages of 200-500 mg/day.
- Moderate-quality evidence indicates that short-term use (up to 60 days) of quinine does not significantly increase serious adverse events compared to placebo.
- Further research is needed on optimal dosage, duration, and alternative treatments for muscle cramps.
More Related Videos
16:16Membrane Potentials, Synaptic Responses, Neuronal Circuitry, Neuromodulation and Muscle Histology Using the Crayfish: Student Laboratory Exercises
Published on: January 18, 2011
11:56Historical View and Physiology Demonstration at the NMJ of the Crayfish Opener Muscle
Published on: November 9, 2009
Related Concept Videos
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...